Asian shares were mixed on Tuesday after U.S. stock indexes inched to more records at the start of a week of profit updates ...

Sarepta will halt all shipments of Elevidys, its drug for Duchenne muscular dystrophy patients, by Tuesday evening.

Children's Hospital Los Angeles, citing recent U.S. Food and Drug Administration actions, on Monday said it has paused usage of Sarepta Therapeutics' gene therapy Elevidys in all patients with ...

U.S. stock indexes inched to more records to kick off a week full of profit updates from big U.S. companies. The S&P 500 rose ...

A nonprofit in Ohio is navigating uncertainty with several programs on the chopping block. Disability Rights Ohio serves as an advocate for people with disabilities.

Kostas Biliouris, BMO Capital Markets biotech analyst, joins CNBC's 'Squawk on the Street' to discuss the latest details on ...

A Cambridge-based company developing gene therapies for rare diseases is laying off more than a third of its workforce.

Sarepta Therapeutics refused a FDA request to halt shipments of Elevidys, its gene therapy for Duchenne muscular dystrophy ...

PDFgear Scan, Finally, a Truly Free AI Scanner App for All. \| PDFgear today launched PDFgear Scan, the world's first free AI ...

Sarepta Therapeutics lays off 493 workers amid FDA probe, stock drop, and concerns over its gene therapy treatment, Elevidys.

Culver’s, which operates 1,000 locations across 26 states, is opening nearly two dozen new locations before the end of the year. Unsurprisingly, Wisconsin, where Culver’s was founded, has the greatest ...

Mel Cozzi and George Howe, Board of Commissioners for the City of Oregon, join WGN Radio’s Dave Plier to highlight the City of Oregon and all that it has to offer for visitors. Mel and ...